National Diabetes Clinical Care Commission Act

-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes. -- H.R. 2104 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 / S. 3338 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2012: Legislation to amend the Public Health Service Act to require personnel who perform or plan the technical component of either medical imaging examinations or radiation therapy procedures for medical purposes to possess certain certification or licensure, effective January 1, 2014, and for other purposes.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act S. 2236, Advancing Breakthrough Therapies for Patients Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 3187 Food and Drug Administration Safety & Innovation Act H.R. 6309, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act. H.R. 2960/S. 3430 National Diabetes Clinical Care Commission Act H.R. 3150/S. 725 Medicare Safe Needle Disposal Coverage Act of 2011

Client expense: $370,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Prescription Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA. - Medical Device User Fee Act Reauthorization. - HR 1483, "The Drug Safety Enhancement Act of 2011", regarding all provisions. - HR 3847, "Safety of Untested and New Devices Act of 2012", regarding all provisions. - HR 3975, "A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007", regarding all provisions. - S 2113, "A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health." regarding all provisions. - S 2193, "Ensuring Safe Medical Devices for Patients", regarding all provisions. - HR 5, "Protecting Access to Healthcare (PATH) Act", regarding all provisions. - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - HR 5937, "Breast Cancer Patient Education Act of 2012", regarding all provisions. - HR 5998, "USPSTF Transparency and Accountability Act of 2012", regarding all provisions. - S 3187, "Food and Drug Administration Safety and Innovation Act", regarding all provisions. - S 2516, "Food and Drug Administration Safety and Innovation Act", regarding all provisions.

S. 3187, Food and Drug Administration Safety and Innovation Act, provisions relating to drug shortages, antibiotic incentives, and combating diversion H.R. 5998, USPSTF Transparency and Accountability Act of 2012, all provisions H.R. 2119, Ryan Creedon Act of 2011, all provisions H.R. 3497, MODDERN Cures Act of 2011, all provisions H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all provisions H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011, all provisions H.R. 2182, Generating Antibiotic Incentives Now Act of 2011, all provisions H.R. 2960, National Diabetes Clinical Care Commission Act, all provisions H.R. 4384, Patient Safety and Drug Labeling Improvement Act, all provisions Clinical Registries ACA Implementation Insurance Exchanges Prescription Drug Abuse Drug diversion/mandatory CME for DEA Registrants/violence prevention Drug shortages Flexible Spending Accounts (FSAs) Delivery and Payment Reform Personalized Medicine Health Information Technology HIPAA Administrative Simplifications Health Insurance Reform Medical Licensing Boards and Scope of Practice

Client expense: $3,680,000 · Firm income: Not reported

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda

Client expense: $400,000 · Firm income: Not reported

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda

Client expense: Not reported · Firm income: $30,000

H.R. 2182, Generating Antibiotic Incentives Now Act of 2011, all provisions S. 1734, Generating Antibiotic Incentives Now Act of 2011, all provisions H.R. 4095, Online Pharmacy Safety Act, all provisions S. 2002, Online Pharmacy Safety Act, all provisions H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011, all provisions S. 296, Preserving Access to Life-Saving Medications Act, all provisions H.R. 2086, Medical Debt Responsibility Act of 2011, all provisions S. 2149, Medical Debt Responsibility Act of 2012, all provisions H.R. 5651, Food and Drug Administration Reform Act of 2012, all provisions S. 3187, Food and Drug Administration Safety and Innovation Act, all provisions H.R. 2960, National Diabetes Clinical Care Commission Act, all provisions S. 2295, Patient Safety and Generic Labeling Improvement Act , all provisions H.R. 2119, Ryan Creedon Act of 2011, all provisions H.R. 3497, MODDERN Cures Act of 2011, all provisions H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all provisions H.R. 2939, Pharmaceutical Stewardship Act of 2011, all provisions H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011, all provisions H.R. 3839, Drug Shortage Prevention Act of 2012, all provisions H.R. 5842, Restoring Access to Medication Act of 2012, all provisions S.Amdt. 2151, To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug Mandatory CME for DEA Registrants Bath Salts Tanning Beds Affordable Care Act Insurance exchanges Violence Against Women Act, provisions relating to quality Drug Shortages Prescription Drug Abuse Next generation antibiotics Scope of Practice Health Insurance Reform Health Information Technology Flexible Spending Accounts/OTC medications Tax deduction for physician charity care HIPAA Administrative Simplification HIPAA privacy and security standards Regulation of energy beverages Unique Device Identification System Multi-Payor Claims Database Private payer guidelines for reporting data to physicians

-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes. -- H.R. 2104 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 / S. 3338 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2012: Legislation to amend the Public Health Service Act to require personnel who perform or plan the technical component of either medical imgaing examinations or radiation therapy procedures for medical purposes to possess certain certification or licensure, effective January 1, 2014, and for other purposes.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Prescription Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3209, "Premarket Predictability Act of 2011", regarding all provisions. - HR 3203/ S 1943, "Novel Device Regulatory Relief Act of 2011", regarding all provisions. - HR 3230, "Keeping America Competitive Through Harmonization Act of 2011", regarding all provisions. - HR 3211, "Humanitarian Device Reform Act of 2011", regarding all provisions. - HR 3208, "Patients Come First Act of 2011", regarding all provisions. - HR 3206, "Cultivating Scientific Expertise to Foster Inovation for Patients Act of 2011", regarding all provisions. - HR 3214/ S 1972, "Food and Drug Administration Mission Reform Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - HR 3204, "Guidance Accountability and Transparency Act of 2011", regarding all provisions. - HR 3205, "FDA Renewing Efficiency From Outside Reviewer Management Act of 2011", regarding all provisons. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA. - Medical Device User Fee Act Reauthorization. - HR 1483, "The Drug Safety Enhancement Act of 2011", regarding all provisions. - HR 3847, "Safety of Untested and New Devices Act of 2012", regarding all provisions. - HR 3975, "A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007", regarding all provisions. - S 2113, "A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health." regarding all provisions. - S 2193, "Ensuring Safe Medical Devices for Patients", regarding all provisions. - HR 5, "Protecting Acess to Healthcare (PATH) Act", regarding all provisions. - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards.

H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2960, National Diabetes Clinical Care Commission Act S. 2236, Advancing Breakthrough Therapies for Patients Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 3187 Food and Drug Administration Safety & Innovation Act S. 725, Medicare Safe Needle Disposal Coverage Act of 2011

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2960, National Diabetes Clinical Care Commission Act S. 2236, Advancing Breakthrough Therapies for Patients Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 3187 Food and Drug Administration Safety & Innovation Act S. 725, Medicare Safe Needle Disposal Coverage Act of 2011

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2960, National Diabetes Clinical Care Commission Act S. 2236, Advancing Breakthrough Therapies for Patients Act H.R. 2969/S. 1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Prescription Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3209, "Premarket Predictability Act of 2011", regarding all provisions. - HR 3203/ S 1943, "Novel Device Regulatory Relief Act of 2011", regarding all provisions. - HR 3230, "Keeping America Competitive Through Harmonization Act of 2011", regarding all provisions. - HR 3211, "Humanitarian Device Reform Act of 2011", regarding all provisions. - HR 3208, "Patients Come First Act of 2011", regarding all provisions. - HR 3206, "Cultivating Scientific Expertise to Foster Inovation for Patients Act of 2011", regarding all provisions. - HR 3214/ S 1972, "Food and Drug Administration Mission Reform Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - HR 3204, "Guidance Accountability and Transparency Act of 2011", regarding all provisions. - HR 3205, "FDA Renewing Efficiency From Outside Reviewer Management Act of 2011", regarding all provisons. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA. - Medical Device User Fee Act Reauthorization. - HR 1483, "The Drug Safety Enhancement Act of 2011", regarding all provisions. - HR 3847, "Safety of Untested and New Devices Act of 2012", regarding all provisions. - HR 3975, "A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007", regarding all provisions. - S 2113, "A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health." regarding all provisions. - S 2193, "Ensuring Safe Medical Devices for Patients", regarding all provisions. - HR 5, "Protecting Acess to Healthcare (PATH) Act", regarding all provisions. - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards.

Supporting Increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs - related to Medicare Share Savings Program, Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; H.R. 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012.

Client expense: Not reported · Firm income: $30,000

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda

Client expense: $670,000 · Firm income: Not reported

Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding minority health, diabetes screening, National Diabetes Prevention Program. H.R. 2954, The Health Equity and Accountability Act of 2011. H.R. 2960, National Diabetes Clinical Care Commission Act. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - Issues related to the Better Act - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Physician Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3209, "Premarket Predictability Act of 2011", regarding all provisions. - HR 3203/ S 1943, "Novel Device Regulatory Relief Act of 2011", regarding all provisions. - HR 3230, "Keeping America Competitive Through Harmonization Act of 2011", regarding all provisions. - HR 3211, "Humanitarian Device Reform Act of 2011", regarding all provisions. - HR 3208, "Patients Come First Act of 2011", regarding all provisions. - HR 3206, "Cultivating Scientific Expertise to Foster Inovation for Patients Act of 2011", regarding all provisions. - HR 3214/ S 1972, "Food and Drug Administration Mission Reform Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - HR 3204, "Guidance Accountability and Transparency Act of 2011", regarding all provisions. - HR 3205, "FDA Renewing Efficiency From Outside Reviewer Management Act of 2011", regarding all provisons. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA.

H.R. 1862, Regenerative Medicine Promotion Act of 2011 H.R. 2787/S. 1468, Medicare Diabetes Self-Management Training Act H.R. 2376, Stem Cell Research Advancement Act of 2011 H.R. 2960, National Diabetes Clinical Care Commission Act H.R. 2969/S. 1454, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011

Client expense: $40,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Supporting Increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs - related to Medicare Share Savings Program, Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; H.R. 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012.

Client expense: Not reported · Firm income: $30,000

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults

Client expense: $386,000 · Firm income: Not reported

Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding minority health, diabetes screening, National Diabetes Prevention Program. H.R. 2954, The Health Equity and Accountability Act of 2011. H.R. 2960, National Diabetes Clinical Care Commission Act. S. 1599, FY 2012 Labor-HHS Appropriations.

Client expense: Not reported · Firm income: $60,000

-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - Issues regarding personalized medicine - Issues related to the Medical Device User Fee Program. - Issues related to the Better Act - Issues related to the Personalized Medicine Bill - Issues related to Diagnostics. - S. 1001, "Safe Doses Act", regarding all provisions. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Physician Drug User Fee Act, regarding all provisions - MODERN Cures Act, regarding all provisions. - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research.

Client expense: $1,770,000 · Firm income: Not reported

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012

Client expense: $910,000 · Firm income: Not reported